Conferences and symposiums

Frontiers in Cancer Research and Therapy

2017-02-2408:30 to 17:00 Nobel ForumCampus Solna

Friday, February 24 (preliminary program)

8:30-9:00                          
Morning Coffee

SESSION 4: Novel biomarkers and cancer therapy, part I
Chairs: Andreas Lundqvist, Anita Göndör

9:00–9:30 
Theodoros Foukakis, Karolinska Institutet
Title: Optimizing current and emerging therapies in breast cancer

9:30-10:00                    
Cecilia Söderberg Naucler, Karolinska Institutet
Title: Is there a role for human cytomegalovirus in tumors or different origin?

10:00–10:30                                           
Johanna Olweus, University of Oslo
Title: Fighting cancer with donor-derived T cell receptors

10:30-11:00
Hans-Gustaf Ljunggren, Karolinska Institutet
Title: NK cell-mediated treatment of human cancer

11:00–11:30                                           
Coffee break

Novel biomarkers and cancer therapy, part II

Chairs: Andreas Lundqvist, Charlotte Rolny

11:30–12:00 
Joan Massaque, Memorial Sloan Kettering Cancer Center
Title: Latency, immune evasion and outbreak of metastatic stem cells

12:00–12:30                                           
Michele De Palma, EPFL
Title: Reprogramming the immune tumor microenvironment for anticancer therapy

12:30–13:30                                          
Renata Pasqualini, University of New Mexico
Title: Ligand-Directed Targeting and Molecular Imaging Based on in Vivo Phage Display

13:00-14:00
Lunch and poster session

SESSION 5: Lung cancer, part I
Chairs: Kristina Viktorsson, Luigi De Petris

14:00–14:30 
Marcin Imielinski, Weill Cornell Medicine
Title: Insertions and deletions target lineage defining genes in human cancer

14:30-15:00                                          
Rafael Rosell, Autonomous University of Barcelona
Title: Compensatory signaling pathways in response to EGFR inhibitors in NSCLC

15:00–15:30                                         
Ping Yang, Mayo Clinic
Title: Transdisciplinary Research in Lung Cancer and COPD

15:30-16:00                                           
Coffee break                    

Lung cancer, part II
Chairs: Kristina Viktorsson, Per Hydbring

16:00-16:30                                           
Faye M. Johnson, M.D. Anderson CC, University of Texas
Title: Targeting polo-like kinase 1 in mesenchymal non-small cell lung cancer  

16:30-17:00    
Julian Sage, Stanford University
Title: Intra-tumoral heterogeneity and response to therapy in small cell lung cancer

17:00-17:30                                    
Closing words and department awards
Dan Grandér, Head of Department of Oncology-Pathology

Contact person: Ola LarssonImport to calendar